Thrombosis
302
29
37
166
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
28 trials with published results (9%)
Research Maturity
166 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
17 terminated out of 302 trials
90.7%
+4.2% vs benchmark
23%
69 trials in Phase 3/4
17%
28 of 166 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 166 completed trials
Clinical Trials (302)
Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient
Platelet Volunteers, Longitudinal and Multi-omic Study
CES1 Crossover Trial of Clopidogrel and Ticagrelor
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
Inpatient Monitoring of Unfractionated Heparin
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Thromboprophylaxis in Lower Limb Immobilisation
Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study
Platelets and Extracorporeal Membrane Oxygenation Veno-venous
Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
National Study on the Prevalence of Catheter-Related Venous Thrombosis
A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis
A Phase I SAD/MAD and Liver Effect Study of Vitalangio in Venous Thromboembolism Patients .
Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Antithrombotic Activities of Sotagliflozin vs. Empagliflozin
ATHNdataset Registry
Effectiveness of a Needle-free Connector With Anti-reflux Technology in Reducing Complications From Long Peripheral Venous Catheters in Hospitalised Adult Patients: Randomised Clinical Trial
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD